Back to the complete issue
Monday, 1 July 2019

SPE Capital buys 30% stake in Future Pharma

M&A WATCH- SPE Capital buys 30% stake in Future Pharma: SPE Capital Partners has acquired a 30% stake in Future Pharma Industries (FPI) for EGP 500 mn, SPE Chairman Gamal El Leithy said, according to the local press. The Middle East-focused private equity firm reported in March that it made an undisclosed equity investment in FPI through its SPE AIF I fund. SPE was originally eyeing up to a 40% stake in the Egyptian pharma company. FPI plans to use the proceeds from the transaction to establish six new production lines.

Enterprise is a daily publication of Enterprise Ventures LLC, an Egyptian limited liability company (commercial register 83594), and a subsidiary of Inktank Communications. Summaries are intended for guidance only and are provided on an as-is basis; kindly refer to the source article in its original language prior to undertaking any action. Neither Enterprise Ventures nor its staff assume any responsibility or liability for the accuracy of the information contained in this publication, whether in the form of summaries or analysis. © 2021 Enterprise Ventures LLC.

Enterprise is available without charge thanks to the generous support of EFG Hermes (tax ID: 200-178-385), the leading financial services corporation in frontier emerging markets; SODIC (tax ID: 212-168-002), a leading Egyptian real estate developer; SomaBay (tax ID: 204-903-300), our Red Sea holiday partner; Infinity (tax ID: 474-939-359), the ultimate way to power cities, industries, and homes directly from nature right here in Egypt; CIRA (tax ID: 200-069-608), the leading providers of K-12 and higher level education in Egypt; Orascom Construction (tax ID: 229-988-806), the leading construction and engineering company building infrastructure in Egypt and abroad; and Etisalat Misr (tax ID: 235-071-579), the leading telecoms provider in Egypt; and Abu Auf (tax ID: 584-628-846), the leading health foodmaker in Egypt and the region.